Shengnan Yu
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Cancer Research
- Co-authors
- Kongming WuQian LiuXudong YaoQian ChuXun YuanShuang QinWeiheng ZhaoAnping Li
- Topics
- interferon and immune responses (2 papers)Advanced Image Fusion Techniques (2 papers)HER2/EGFR in Cancer Research (2 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Shengnan Yu
20 papers receiving 921 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 503
- Molecular Biology 376
- Pulmonary and Respiratory Medicine 243
- Immunology 177
- Cancer Research 156
Countries citing papers authored by Shengnan Yu
This map shows the geographic impact of Shengnan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Yu more than expected).
Fields of papers citing papers by Shengnan Yu
This network shows the impact of papers produced by Shengnan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Yu. The network helps show where Shengnan Yu may publish in the future.
Co-authorship network of co-authors of Shengnan Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Yu. A scholar is included among the top collaborators of Shengnan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Yu. Shengnan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | Advances on immunotherapy for osteosarcomabreakdown → | 85 |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 1 | |
| 11 | 17 | |
| 12 | 5 | |
| 13 | 5 | |
| 14 | 38 | |
| 15 | 61 | |
| 16 | EGFR-TKIs resistance via EGFR-independent signaling pathwaysbreakdown → | 288 |
| 17 | 12 | |
| 18 | 234 | |
| 19 | 124 | |
| 20 | 34 |
About Shengnan Yu
Shengnan Yu is a scholar working on Transplantation, Aging and Oncology, having authored 25 papers that have together received 942 indexed citations. Recurring topics across this work include interferon and immune responses (2 papers), Advanced Image Fusion Techniques (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (503 citations), Cancer Research (156 citations) and Immunology (177 citations). Shengnan Yu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Kongming Wu, Qian Liu, Xudong Yao, Qian Chu, Xun Yuan, Shuang Qin, Weiheng Zhao, Anping Li, Qian Liu and Xinwei Han. Their work appears in journals such as Scientific Reports, Molecular Cancer and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.